HCG is a hormone that is naturally produced by the female placenta during a normal pregnancy. This medicine’s action is highly similar to luteinizing hormone (LH), because this hormone is known to be able to cause ovulation. If it is combined with other medicines and drugs, Ovulate is highly effective in helping female patients become pregnant. This drug can also help males patients that are suffering from fertility issues (a treatment with this medicine usually enables such cases to produce a higher amount of testosterone).
Ovulate is a popular medicine that is regularly prescribed to female patients as part of a regimen that is supposed to induce:
- Ovulation induction in subfertility that is usually triggered by impaired follicle-ripening or by anovulation. - Luteal phase support.
- Follicle preparation for puncture in controlled ovarian hyperstimulation programs (this usually occurs in the case of medically assisted reproductive methods and techniques).
Ovulate is a medicine that is regularly prescribed to male patients because of its ability to induce
- Hypogonadotrophic hypogonadism. - Some patients who were suffering from idiopathic dysspermias have positively responded to a treatment with this medicine. - Delayed puberty which is regularly associated with an insufficient function of the gonadotrophic pituitary glands. - Cryptorchidism, (not the one that is triggered by an abnormal anatomical obstruction).
Ovulate is a popular medicine that helps both male and female patients deal with infertility. However, this medicine can also be used for some other purposes (to treat or to prevent some other medical conditions) that have not been listed here.
In the case of female patients who want to be treated with Ovulate:
- Since infertile female patients who undergo medically assisted reproduction (especially those who need in vitro fertilization), are known to often be suffering from tubal abnormalities, after a treatment with this drug they might experience much more ectopic pregnancies. This is why early ultrasound confirmation at the beginning of a pregnancy (to see whether the pregnancy is intrauterine or not) is crucial. - Pregnancies who have occurred after a treatment with this medicine are submitted to a higher risk of multiplets. - Female patients who have thrombosis, severe obesity or thrombophilia should not be prescribed this medicine as they have a higher risk of arterial or venous thromboembolic events after or during a treatment with Ovulate.
- Female patients who have been treated with this medicine are usually more prone to pregnancy losses.
In the case of male patients: A prolonged treatment with Ovulate is known to regularly lead to increased production of androgen. Therefore:
- Patients who are suffering from overt or latent cardiac failure, hypertension, renal dysfunction, migraine or Epilepsy might not be allowed to start using this medicine or might have to be prescribed a lower dose of Ovulate. - This medicine should be used with extreme cautious in the case of prepubertal teenagers in order to reduce the risk of experiencing precocious sexual development or premature epiphyseal closure. This type of patients’ skeletal maturation should be closely and regularly monitored.
Both male and female patients who have the following medical conditions must not start a treatment with Ovulate: - Hypersensitivity to this medicine or to any of its main ingredients. - Known or possible androgen-dependent tumors for example male breast carcinoma or prostatic carcinoma.
Ovulate Intake guidelines
Ask your physician how and when to take this medicine. You should not disobey any of your physician’s indications. You can also consult the drug’s label for further instructions. If you have any other questions, you should refer to a doctor, a pharmacist or a nurse. Ovulate should be stored in the refrigerator, at a temperature that is between 2°-8°C. Keep this medicine away from direct sunlight. Store it in a place that is far from the reach of pets and children in order to avoid unwanted accidents such as poisoning.
Dosage in the case of female patients: They should be administered one injection of 5 000-10 000 I.U. of this medicine. Dosage in the case of male patients: They should be administered an injection of 1000-2000 I.U. of medicine, from 2 to 3 times each week. It is best that each dose of Ovulate should be administered by an authorized medical healthcare provider.
This medicine’s acute toxicity is very low. The average symptoms of an overdose with Ovulate are not known in the case of human patients.
Ovulate Missed Dose
Ask your personal physician what to do in case you miss one of your prescribed doses of Ovulate.
Ovulate Side effects
A prolonged treatment with this medicine is known to trigger several reactions at the injection site (like pain, bruising, redness, itching and swelling). Some patients who had been treated with Ovulate have experienced some allergic reactions to this medicine that were manifesting as rash, pain or swelling at the injection site. Ovulate’s rare side effects are known to include fever or rash.
Female patients who have been treated with this product have experienced unpleasant ovarian hyperstimulation syndrome. In the case of male patients who have received Ovulate, sodium and water retention is occasionally experienced, especially after the patient has been administered a high dose of this medicine (this condition is probably triggered by an excessive androgen production). In some cases, a treatment with Ovulate may sometimes cause gynaecomastia.
Ovulate Drug Reactions
You should ask your personal physician if it is safe to start taking other medicines while being treated with Ovulate.
In some countries Ovulate may also be known as: Dinaron, EndoOvutrig, Gonacor, Ovidrel, Pregnyl, Profasi, Ovitrelle, Choragon, Choriomon, Profasi HP, Ovutrig, Pubergen, APL, Gonic, Novarel, Choron, Oral HCG, Releana, Uni, Hucog, Organon, Lupi, Chorex, Pregnyl IM, Hcg Kits, Hcg Diet, Dr. Simeons, Kevin Trudeau, Hygiene Kit, Lipotropics Injection, Hgc, Ovidac, Zykog, Sigma, High Purity, Kizer